Medistem Advances Type 1 Diabetes Stem Cell Technology Licensed From Yale
Published: Wednesday, September 12, 2012 Last Updated: Wednesday, September 12, 2012
Medistem Inc. announced completion of the first phase of a joint project with the Shumakov Research Center of Transplantology and Artificial Organs of the Russian Federation and its Russian and CIS licensee ERCell.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.